Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Elevated infection parameters and infection symptoms predict an acute coronary event.

Författare

  • Erkki Pesonen
  • Eva Andsberg
  • Anders Grubb
  • Hilpi Rautelin
  • Seppo Meri
  • Kenneth Persson
  • Mirja Puolakkainen
  • Seppo Sarna
  • Hans Öhlin

Summary, in English

BACKGROUND: The etiology and significance of flu-like symptoms often appearing before myocardial infarction should be clarified. METHODS: In a case-control study of 323 matched controls and a random sample of 110 out of 351 cases the presence of infection symptoms during the preceding four weeks before admission were asked and blood samples taken. RESULTS: Enterovirus (EV), herpes simplex virus (HSV), and Chlamydia pneumoniae IgA titers were significantly higher in cases than in controls (p<0.001, 0.008 and 0.046, respectively). Flu-like symptoms appeared significantly more often in patients than in controls the most common one being fatigue (p<0.001). In controls with fatigue, EV and HSV titers showed a trend to be higher (1.50 vs 1.45 and 4.29 vs 3.73) than in controls without fatigue but only HSV titers were statistically significantly higher (3.47 vs 3.96, p = 0.02). Even CRP and amyloid A concentrations (3.49 vs 2.08, p<0.0001 and 5.70 vs 3.77 mg/l, p = 0.003, respectively) as well as C4 (0.40 vs 0.44, p = 0.02) were higher in controls with fatigue. CONCLUSIONS: Odds ratios for a coronary event in a logistic regression model were 4.79 for fatigue and 2.72 for EV antibody levels in their fourth quartile. A linear-by-linear association test showed increasing number of single symptoms with higher EV titer quartiles (p = 0.004).

Publiceringsår

2008

Språk

Engelska

Sidor

419-424

Publikation/Tidskrift/Serie

Therapeutic Advances in Cardiovascular Disease

Volym

2

Issue

6

Dokumenttyp

Artikel i tidskrift

Förlag

SAGE Publications

Ämne

  • Microbiology in the medical area
  • Medicinal Chemistry
  • Pediatrics
  • Pharmacology and Toxicology
  • Cardiac and Cardiovascular Systems

Status

Published

Forskningsgrupp

  • Clinical Microbiology, Malmö

ISBN/ISSN/Övrigt

  • ISSN: 1753-9447